Top Small Cap Stocks For 2019

Small cap late-stage biopharmaceutical stock Achaogen Inc (NASDAQ: AKAO) has elevated short interest of 39.87% according to Highshortinterest.com. Achaogen is a late-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative antibacterial treatments for MDR gram-negative infections. Achaogen is developing plazomicin, its lead product candidate, for the treatment of serious bacterial infections due to MDR Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae. The FDA has granted plazomicin Breakthrough Therapy designation for the treatment of bloodstream infections caused by certain Enterobacteriaceae in patients who have limited or no alternative treatment options. The Company’s second product candidate is C-Scape, an orally-administered product candidate for the treatment of serious bacterial infections due to ESBL-producing Enterobacteriaceae. Achaogen’s plazomicin program has been funded, and its C-Scape program is funded, in part with federal funds from the Biomedical Advanced Research and Development Authority (BARDA). Achaogen has other programs in early and late preclinical stages of development focused on other MDR gram-negative infections and additional disease areas. All product candidates are investigational only and have not been approved for commercialization.

Top Small Cap Stocks For 2019: ATA Inc.(ATAI)

Advisors’ Opinion:

  • [By Paul Ausick]

    ATA Inc. (NASDAQ: ATAI) traded down about 14% Monday to set a new 52-week low of $0.82, based on revalued shares that closed at $0.72 on Friday but traded up about 250% on Monday at $2.53. Volume was more than 200 times the daily average of around 42,000. You’re on your own here to figure this one out.

Top Small Cap Stocks For 2019: FuelCell Energy Inc.(FCEL)

Advisors’ Opinion:

  • [By Paul Ausick]

    FuelCell Energy Inc. (NASDAQ: FCEL) posted a dip of 1.9% in short interest during the two-week period. Some 10.41 million shares were short as of July 31. The stock closed at $1.20 on Thursday, up more than 11% for the day, in a 52-week range of $1.07 to $2.49. Shares traded down about 2.6% in the short interest period, and days to cover slipped from 11 to nine.

  • [By Logan Wallace]

    FuelCell Energy (NASDAQ: FCEL) and HRG Group (NYSE:HRG) are both oils/energy companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, analyst recommendations, institutional ownership, earnings and profitability.

  • [By Paul Ausick]

    FuelCell Energy Inc. (NASDAQ: FCEL) posted a dip of 0.5% in short interest during the two weeks. Some 9.88 million shares were short as of August 31. The stock closed at $1.08 on Wednesday, up about 1.9% for the day, in a 52-week range of $1.00 to $2.49. Shares traded up about 14.4% in the two-week short interest period, and days to cover rose from nine to 12.

Top Small Cap Stocks For 2019: Sky-mobi Limited(MOBI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Media coverage about Sky-mobi (NASDAQ:MOBI) has trended somewhat positive this week, according to Accern Sentiment. The research group ranks the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Sky-mobi earned a news impact score of 0.06 on Accern’s scale. Accern also assigned news stories about the software maker an impact score of 45.6853785900783 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

  • [By Logan Wallace]

    Mobius (CURRENCY:MOBI) traded up 0.1% against the dollar during the 24 hour period ending at 18:00 PM ET on February 11th. In the last week, Mobius has traded 3.1% lower against the dollar. One Mobius token can now be bought for approximately $0.0095 or 0.00000260 BTC on exchanges including OTCBTC, Gate.io, Stellar Decentralized Exchange and BitMart. Mobius has a total market capitalization of $4.89 million and approximately $19,445.00 worth of Mobius was traded on exchanges in the last day.

  • [By Ethan Ryder]

    Mobius (CURRENCY:MOBI) traded 1.2% lower against the dollar during the 1-day period ending at 14:00 PM E.T. on August 21st. In the last week, Mobius has traded down 1.1% against the dollar. One Mobius token can now be bought for about $0.0291 or 0.00000452 BTC on popular cryptocurrency exchanges including GOPAX, BitMart, Gate.io and Stellar Decentralized Exchange. Mobius has a total market capitalization of $11.23 million and approximately $78,528.00 worth of Mobius was traded on exchanges in the last 24 hours.

  • [By Stephan Byrd]

    Mobius (CURRENCY:MOBI) traded 5.5% higher against the dollar during the 24-hour period ending at 16:00 PM E.T. on February 21st. Mobius has a market cap of $6.06 million and $37,433.00 worth of Mobius was traded on exchanges in the last 24 hours. One Mobius token can now be purchased for $0.0118 or 0.00000298 BTC on popular cryptocurrency exchanges including GOPAX, Gate.io, BitMart and Stellarport. Over the last seven days, Mobius has traded up 22.4% against the dollar.

  • [By Logan Wallace]

    Mobius (CURRENCY:MOBI) traded 12.4% lower against the US dollar during the 24 hour period ending at 17:00 PM E.T. on September 25th. One Mobius token can now be bought for approximately $0.0265 or 0.00000414 BTC on major cryptocurrency exchanges including Gate.io, Kucoin, BitMart and GOPAX. Over the last week, Mobius has traded up 8.8% against the US dollar. Mobius has a market cap of $10.22 million and approximately $69,762.00 worth of Mobius was traded on exchanges in the last day.

Top Small Cap Stocks For 2019: Achillion Pharmaceuticals Inc.(ACHN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Achillion Pharmaceuticals (NASDAQ:ACHN) has been given an average recommendation of “Hold” by the nine brokerages that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating on the company. The average 12 month price target among analysts that have covered the stock in the last year is $5.20.

  • [By Keith Speights]

    Skeptics might deride a comparison of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) and Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) as an exercise in finding the biggest loser. Both companies continue to post huge net losses every quarter, and their stocks are down by at least 30% over the last 12 months.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Leave a Reply

Your email address will not be published. Required fields are marked *